Received Apr 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
No side effects or symptoms reported; HCP reported that a patient received their second dose of GARDASIL 9 approximately 10 years ago and has not received their third dose; This spontaneous report was received from a pharmacist referring to a 24-years-old female patient. The patient's pertinent medical history, known drug reactions or allergies, and concomitant therapies were not reported. On an unspecified date in 2026 (reported as approximately 10 years ago), the patient received their second dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) as prophylaxis (dose, route of administration, anatomical site, lot #, and expiration date were not reported) and had not received their third dose (Inappropriate schedule of product administration). No side effects or symptoms reported (No adverse event). Lot # is being requested and will be submitted if received.